Hugh Wight
Chief Tech/Sci/R&D Officer presso ALLENA PHARMACEUTICALS, INC.
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Alexey L. Margolin | M | 71 |
Alnara Pharmaceuticals, Inc.
 Alnara Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alnara Pharmaceuticals, Inc. develops and commercializes protein therapeutics for the treatment of metabolic diseases. It also develops liprotamase, a non-porcine pancreatic enzyme replacement therapy (PERT) for the treatment of exocrine pancreatic insufficiency (EPI). The company was founded by Christoph H. Westphal, Richard H. Aldrich and Alexy L. Margolin in 2008 and is headquartered in Boston, MA. | 16 anni |
| Mark J. Fitzpatrick | M | 61 | 3 anni | |
| Geoffrey A. Swire | M | - | 6 anni | |
| Ann Miller | M | 66 | 4 anni | |
| Matthew Foster | M | - | 2 anni |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Jane L. Caron | F | - |
University of Maine
| 7 anni |
| Andrew J. Frawley | M | 61 |
University of Maine
| 4 anni |
| Charles N. Kasmer | M | - |
University of Maine
| 4 anni |
| Dean H. Murray | M | - |
University of Maine
| 5 anni |
| Ray Carter | M | - |
University of Maine
| 4 anni |
| Joe A. Farrell | M | - |
University of Maine
| 3 anni |
| Jon W. Chadbourne | M | - |
University of Maine
| 4 anni |
| David Nonis | M | - |
University of Maine
| 4 anni |
| Michael W. Murphy | M | - |
University of Maine
| 3 anni |
| Wayne Steller | M | - |
University of Maine
| 4 anni |
| Michael Martin Young | M | - |
University of Maine
| 4 anni |
| Michael Bilodeau | M | 62 |
University of Maine
| 4 anni |
| James M. Rice | M | - |
University of Maine
| 4 anni |
| John Beaupre | M | - |
University of Maine
| 4 anni |
| Chris Stevens | M | 65 |
Alnara Pharmaceuticals, Inc.
Alnara Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alnara Pharmaceuticals, Inc. develops and commercializes protein therapeutics for the treatment of metabolic diseases. It also develops liprotamase, a non-porcine pancreatic enzyme replacement therapy (PERT) for the treatment of exocrine pancreatic insufficiency (EPI). The company was founded by Christoph H. Westphal, Richard H. Aldrich and Alexy L. Margolin in 2008 and is headquartered in Boston, MA. | 2 anni |
| Matthew L. Chase | M | - |
University of Maine
| 4 anni |
| Barry Peters | M | - |
University of Maine
| 4 anni |
| Matthew Wright | M | - |
University of Maine
| 4 anni |
| Andrew Sawyer | M | - |
University of Maine
| 4 anni |
| Kevin Blayne | M | - |
University of Maine
| 4 anni |
| Thomas Rowland | M | 58 |
Alnara Pharmaceuticals, Inc.
Alnara Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alnara Pharmaceuticals, Inc. develops and commercializes protein therapeutics for the treatment of metabolic diseases. It also develops liprotamase, a non-porcine pancreatic enzyme replacement therapy (PERT) for the treatment of exocrine pancreatic insufficiency (EPI). The company was founded by Christoph H. Westphal, Richard H. Aldrich and Alexy L. Margolin in 2008 and is headquartered in Boston, MA. | - |
| Kerry Perkins | M | - |
University of Maine
| 4 anni |
| Scott Toothaker | M | 61 |
University of Maine
| 4 anni |
| Clayton E. Andrews | M | 61 |
University of Maine
| 4 anni |
| Ashley L. Dombkowski | M | - |
Alnara Pharmaceuticals, Inc.
Alnara Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alnara Pharmaceuticals, Inc. develops and commercializes protein therapeutics for the treatment of metabolic diseases. It also develops liprotamase, a non-porcine pancreatic enzyme replacement therapy (PERT) for the treatment of exocrine pancreatic insufficiency (EPI). The company was founded by Christoph H. Westphal, Richard H. Aldrich and Alexy L. Margolin in 2008 and is headquartered in Boston, MA. | - |
| Charles G. Bridge | M | 57 |
University of Maine
| 4 anni |
| Brian Alan Bickford | M | - |
University of Maine
| 3 anni |
| Scott P. Conners | M | 56 |
University of Maine
| 4 anni |
| Glen Riley | M | 61 |
University of Maine
| 4 anni |
| Jenifer Lynne Butler | F | - |
University of Maine
| 4 anni |
| Lee R. Brettman | M | 77 |
Alnara Pharmaceuticals, Inc.
Alnara Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alnara Pharmaceuticals, Inc. develops and commercializes protein therapeutics for the treatment of metabolic diseases. It also develops liprotamase, a non-porcine pancreatic enzyme replacement therapy (PERT) for the treatment of exocrine pancreatic insufficiency (EPI). The company was founded by Christoph H. Westphal, Richard H. Aldrich and Alexy L. Margolin in 2008 and is headquartered in Boston, MA. | - |
| Paul Walsh | M | 59 |
University of Maine
| 4 anni |
| James A. Montembeau | M | - |
University of Maine
| 4 anni |
| Robert Gallotto | M | 59 |
Alnara Pharmaceuticals, Inc.
Alnara Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alnara Pharmaceuticals, Inc. develops and commercializes protein therapeutics for the treatment of metabolic diseases. It also develops liprotamase, a non-porcine pancreatic enzyme replacement therapy (PERT) for the treatment of exocrine pancreatic insufficiency (EPI). The company was founded by Christoph H. Westphal, Richard H. Aldrich and Alexy L. Margolin in 2008 and is headquartered in Boston, MA. | - |
| Darryl Withrow | M | 59 |
University of Maine
| 4 anni |
| Todd M. Pierce | M | - |
University of Maine
| 4 anni |
| Bruce G. Nickerson | M | - |
University of Maine
| 3 anni |
| Mark R. Stone | M | 61 |
University of Maine
| 4 anni |
| Richard L. Mooers | M | 60 |
University of Maine
| 4 anni |
| Robert Stolz | M | - |
University of Maine
| 4 anni |
| Ralph S. Baker | M | - |
University of Maine
| 1 anni |
| Matthew McHatten | M | - |
University of Maine
| 4 anni |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Stati Uniti | 47 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Hugh Wight
- Contatti personali
